In line with this, it has been reported that melatonin administration can reduce depressive-like behaviour in an animal model of depression by reducing NLRP3 inflammasome activation through the activation of Nrf2 and the silent information regulator 2 homolog 1 (SIRT1), which have antioxidant actions [101]. This evidence concerns the gene NFE2L2 and depressive symptom measurement.